Related Experiment Video
Updated: Aug 4, 2026
08:09
Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
Published on: January 7, 2014
Pathogenesis of Parkinson's disease
1Department of Clinical Neurosciences, Royal Free Hospital School of Medicine, London, UK.
Bailliere'S Clinical Neurology
|April 1, 1997
Summary
Parkinson's disease (PD) likely has multiple causes, not a single one. Research is exploring genetic links and cellular damage, like mitochondrial dysfunction, to understand dopaminergic cell loss in PD.
Area of Science:
- Neuroscience
- Genetics
- Cell Biology
Background:
- The exact causes and mechanisms of Parkinson's disease (PD) are still unknown.
- Emerging consensus suggests multiple etiological factors contribute to PD's clinical and pathological features.
- Genetic factors are implicated in PD's causation or susceptibility.
Purpose of the Study:
- To investigate the genetic underpinnings of Parkinson's disease.
- To explore potential biochemical deficiencies responsible for selective dopaminergic cell death.
- To understand factors contributing to substantia nigral cell loss in PD.
Main Methods:
- Linkage analysis in a family with autosomal dominant parkinsonism.
- Identification of gene mutations, specifically in the alpha-synuclein gene.
- Examination of cellular factors like mitochondrial dysfunction and oxidative damage.
Main Results:
- A gene for autosomal dominant parkinsonism was linked to chromosome 4q21-23.
- A mutation in the alpha-synuclein gene was identified in this region.
- Potential common pathways like mitochondrial dysfunction and oxidative stress were highlighted.
Conclusions:
- Identifying alpha-synuclein gene mutations is a significant step toward understanding PD's biochemical basis.
- The relevance of identified genetic defects to sporadic PD requires further investigation.
- Understanding cellular damage mechanisms may offer crucial insights into PD's diverse etiologies.
More Related Videos
Related Concept Videos
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...